Teva Quits PhRMA As Financial, Policy Challenges Loom For The Brand/Generic Hybrid Giant

 
• By Derrick Gingery

With a leadership position in the US generics association and a new CEO focused on how to reallocate resources, Teva leaves the brand trade association after a review of the ‘effectiveness and value of engagements.’

Teva and PhRMA are going their separate ways in 2023. • Source: Nielsen Hobbs; the Pink Sheet | Shutterstock images

More from Legislation

More from Pink Sheet